Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBITDA (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of EBITDA data on record, last reported at -$1.9 million in Q4 2012.

  • For Q4 2012, EBITDA rose 25.87% year-over-year to -$1.9 million; the TTM value through Dec 2012 reached -$4.7 million, up 36.71%, while the annual FY2012 figure was -$7.5 million, 4.83% up from the prior year.
  • EBITDA reached -$1.9 million in Q4 2012 per SNOA's latest filing, down from -$1.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $325000.0 in Q2 2012 and bottomed at -$2.6 million in Q4 2011.
  • Average EBITDA over 3 years is -$1.7 million, with a median of -$1.7 million recorded in 2012.
  • The widest YoY moves for EBITDA: up 115.17% in 2012, down 38.2% in 2012.
  • A 3-year view of EBITDA shows it stood at -$2.2 million in 2010, then dropped by 15.6% to -$2.6 million in 2011, then rose by 25.87% to -$1.9 million in 2012.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$1.9 million in Q4 2012, -$1.4 million in Q3 2012, and $325000.0 in Q2 2012.